Cardiac morbidity and mortality associated with the use of lamotrigine

OBJECTIVE: The US Food and Drug Administration recently issued a warning against the use of the antiseizure medication lamotrigine in people at risk of cardiac rhythm and conduction abnormalities. This study assessed the risk of cardiac morbidity and mortality in new users of lamotrigine. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Jakob, Trabjerg, Betina B., Dreier, Julie Werenberg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796304/
https://www.ncbi.nlm.nih.gov/pubmed/35735211
http://dx.doi.org/10.1111/epi.17339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796304/
https://www.ncbi.nlm.nih.gov/pubmed/35735211
http://dx.doi.org/10.1111/epi.17339

Ejemplares similares